Silence Therapeutics (SLN) Change in Receivables (2024 - 2025)
Silence Therapeutics (SLN) posted Change in Receivables of -$30000.0 for Q4 2025, up 51.61% sequentially from -$62000.0 in Q3 2025, and down 104.91% YoY from $611000.0 in Q4 2024.
Silence Therapeutics (SLN) Change in Receivables (2024 - 2025) Analysis & Trends
Silence Therapeutics has reported Change in Receivables for 2 years, with the latest figure at -$30000.0 in Q4 2025.
- Quarterly Change in Receivables fell 104.91% year-over-year to -$30000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$84000.0 (up 99.16% YoY) and the FY2025 annual result came in at -$1.0 million, down 213.27% from the prior year.
- Change in Receivables advanced to -$30000.0 in Q4 2025 per SLN's latest filing, from -$62000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $10.0 million in Q1 2024 and troughed at -$8.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30,000.00 |
| Dec 31, 2025 | -30,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -940,000.00 |
| Mar 31, 2025 | -940,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Sep 30, 2024 | -1.75 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -7.97 Mn |
| Jun 30, 2024 | -7.97 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Mar 31, 2024 | 10.01 Mn |